Envestnet Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $100M | Buy |
1,908,549
+70,805
| +4% | +$3.74M | 0.02% | 572 |
|
|
2026
Q1 | $101M | Sell |
1,837,744
-806,986
| -31% | -$43.7M | 0.03% | 527 |
|
|
2025
Q4 | $130M | Sell |
2,644,730
-548,539
| -17% | -$25.6M | 0.04% | 418 |
|
|
2025
Q3 | $138M | Sell |
3,193,269
-342,567
| -10% | -$13.4M | 0.04% | 416 |
|
|
2025
Q2 | $136M | Buy |
3,535,836
+1,399,498
| +66% | +$53.5M | 0.04% | 407 |
|
|
2025
Q1 | $82.8M | Buy |
2,136,338
+247,966
| +13% | +$9.08M | 0.03% | 533 |
|
|
2024
Q4 | $63.9M | Sell |
1,888,372
-198,468
| -10% | -$7.14M | 0.02% | 604 |
|
|
2024
Q3 | $85.3M | Buy |
2,086,840
+37,265
| +2% | +$1.52M | 0.03% | 523 |
|
|
2024
Q2 | $78.9M | Buy |
2,049,575
+4,877
| +0.2% | +$205K | 0.03% | 508 |
|
|
2024
Q1 | $87.7M | Buy |
2,044,698
+148,964
| +8% | +$6.14M | 0.03% | 476 |
|
|
2023
Q4 | $70.3M | Buy |
1,895,734
+270,149
| +17% | +$9.7M | 0.03% | 489 |
|
|
2023
Q3 | $58.9M | Buy |
1,625,585
+638,544
| +65% | +$22.7M | 0.03% | 516 |
|
|
2023
Q2 | $35.2M | Sell |
987,041
-520,091
| -35% | -$18.7M | 0.02% | 642 |
|
|
2023
Q1 | $23.3M | Buy |
1,507,132
+958,558
| +175% | +$33.5M | 0.01% | 805 |
|
|
2022
Q4 | $19.3M | Sell |
548,574
-73,718
| -12% | -$2.46M | 0.01% | 880 |
|
|
2022
Q3 | $18.3M | Buy |
+622,292
| New | +$23.6M | 0.01% | 827 |
|
|
2022
Q2 | – | Sell |
-523,378
| Closed | -$28.5M | – | 3973 |
|
|
2022
Q1 | $28.5M | Buy |
523,378
+109,545
| +26% | +$5.95M | 0.01% | 689 |
|
|
2021
Q4 | $22.8M | Buy |
413,833
+159,422
| +63% | +$8.29M | 0.01% | 786 |
|
|
2021
Q3 | $12.2M | Buy |
254,411
+35,163
| +16% | +$1.77M | 0.01% | 1033 |
|
|
2021
Q2 | $10.9M | Buy |
219,248
+24,172
| +12% | +$1.16M | 0.01% | 1078 |
|
|
2021
Q1 | $8.7M | Sell |
195,076
-69,894
| -26% | -$3.17M | 0.01% | 1121 |
|
|
2020
Q4 | $12.2M | Sell |
264,970
-494,856
| -65% | -$22.7M | 0.01% | 821 |
|
|
2020
Q3 | $35.8M | Sell |
759,826
-57,776
| -7% | -$2.89M | 0.03% | 387 |
|
|
2020
Q2 | $41.7M | Sell |
817,602
-126,441
| -13% | -$6.49M | 0.04% | 324 |
|
|
2020
Q1 | $44.7M | Sell |
944,043
-22,710
| -2% | -$1.21M | 0.05% | 252 |
|
|
2019
Q4 | $56.8M | Buy |
966,753
+74,408
| +8% | +$4.14M | 0.06% | 252 |
|
|
2019
Q3 | $47.6M | Buy |
892,345
+23,380
| +3% | +$1.2M | 0.05% | 271 |
|
|
2019
Q2 | $43.5M | Buy |
868,965
+31,624
| +4% | +$1.59M | 0.05% | 259 |
|
|
2019
Q1 | $43.7M | Buy |
837,341
+50,588
| +6% | +$2.53M | 0.06% | 240 |
|
|
2018
Q4 | $37.6M | Buy |
786,753
+773,256
| +5,729% | +$38.1M | 0.06% | 229 |
|
|
2018
Q3 | $678K | Sell |
13,497
-148,564
| -92% | -$7.55M | ﹤0.01% | 853 |
|
|
2018
Q2 | $8.16M | Buy |
162,061
+8,017
| +5% | +$404K | 0.02% | 369 |
|
|
2018
Q1 | $7.53M | Sell |
154,044
-132,489
| -46% | -$6.17M | 0.02% | 296 |
|
|
2017
Q4 | $12.7M | Sell |
286,533
-120,163
| -30% | -$5.55M | 0.03% | 341 |
|
|
2017
Q3 | $20.6M | Buy |
406,696
+26,326
| +7% | +$1.34M | 0.05% | 211 |
|
|
2017
Q2 | $20.5M | Buy |
380,370
+8,595
| +2% | +$458K | 0.06% | 205 |
|
|
2017
Q1 | $19.6M | Buy |
371,775
+16,742
| +5% | +$849K | 0.06% | 203 |
|
|
2016
Q4 | $17.1M | Sell |
355,033
-62,234
| -15% | -$3.07M | 0.06% | 224 |
|
|
2016
Q3 | $22.5M | Sell |
417,267
-42,579
| -9% | -$2.33M | 0.09% | 176 |
|
|
2016
Q2 | $24.9M | Buy |
459,846
+23,364
| +5% | +$1.23M | 0.1% | 174 |
|
|
2016
Q1 | $22.1M | Buy |
436,482
+18,159
| +4% | +$904K | 0.1% | 186 |
|
|
2015
Q4 | $21.1M | Sell |
418,323
-3,074
| -0.7% | -$157K | 0.1% | 187 |
|
|
2015
Q3 | $20.3M | Buy |
421,397
+4,223
| +1% | +$220K | 0.1% | 179 |
|
|
2015
Q2 | $21.7M | Buy |
417,174
+9,356
| +2% | +$527K | 0.1% | 192 |
|
|
2015
Q1 | $23.5M | Buy |
407,818
+393,373
| +2,723% | +$22.6M | 0.12% | 172 |
|
|
2014
Q4 | $772K | Sell |
14,445
-1,187
| -8% | -$66.4K | 0.01% | 589 |
|
|
2014
Q3 | $898K | Buy |
15,632
+3,456
| +28% | +$212K | 0.01% | 601 |
|
|
2014
Q2 | $814K | Sell |
12,176
-1,449
| -11% | -$98.1K | 0.01% | 620 |
|
|
2014
Q1 | $910K | Buy |
13,625
+5,541
| +69% | +$375K | 0.01% | 489 |
|
|
2013
Q4 | $539K | Buy |
8,084
+106
| +1% | +$6.87K | 0.01% | 610 |
|
|
2013
Q3 | $500K | Buy |
7,978
+756
| +10% | +$48.7K | 0.01% | 609 |
|
|
2013
Q2 | $451K | Buy |
+7,222
| New | +$458K | 0.01% | 609 |
|
Other funds holding GSK
JEST
Envestnet Asset Management's GSK Position: Q2 2026 in Review
Envestnet Asset Management increased its GSK (GSK) stake by 3.9% in Q2 2026, buying an estimated $3.74M and bringing the position to 1,908,549 shares worth $100M. The position accounts for 0.02% of the portfolio, ranked #572.
Envestnet Asset Management first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. The position peaked at $138M in Q3 2025. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Envestnet Asset Management held 1,908,549 shares of GSK worth $100M as of Q2 2026.
- Envestnet Asset Management bought 70,805 GSK shares in Q2 2026, an estimated $3.74M.
- GSK made up 0.02% of Envestnet Asset Management's portfolio in Q2 2026, its #572 holding.
- Envestnet Asset Management first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
- Envestnet Asset Management's GSK position peaked at $138M in Q3 2025.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.